New diabetes pill shows Real-World promise for blood sugar control
NCT ID NCT04878393
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 26 times
Summary
This study followed 650 adults with type 2 diabetes in Japan who were already prescribed the daily pill Rybelsus (oral semaglutide). Researchers tracked changes in blood sugar levels, body weight, and any side effects over 8-10 months. The goal was to see how well the medication works in everyday settings, not a controlled lab.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Master Centre for Japan
Tokyo, 1000005, Japan
Conditions
Explore the condition pages connected to this study.